IE
VIR icon

Israel Englander’s Vir Biotechnology VIR Stock Holding History

Israel Englander’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$489K Sell
47,993
-441,367
-90% -$4.2M ﹤0.01% 4784
2026
Q1 		$4.38M Sell
489,360
-513,246
-51% -$4.09M ﹤0.01% 3097
2025
Q4 		$6.05M Sell
1,002,606
-393,898
-28% -$2.35M ﹤0.01% 2803
2025
Q3 		$7.97M Buy
1,396,504
+787,212
+129% +$4.03M ﹤0.01% 2625
2025
Q2 		$3.07M Buy
609,292
+175,914
+41% +$943K ﹤0.01% 3476
2025
Q1 		$2.81M Sell
433,378
-1,281,705
-75% -$11.4M ﹤0.01% 3454
2024
Q4 		$12.6M Buy
1,715,083
+610,367
+55% +$4.81M 0.01% 1962
2024
Q3 		$8.27M Sell
1,104,716
-143,415
-11% -$1.25M ﹤0.01% 2366
2024
Q2 		$11.1M Buy
1,248,131
+606,804
+95% +$5.82M 0.01% 1993
2024
Q1 		$6.5M Buy
641,327
+231,270
+56% +$2.36M ﹤0.01% 2609
2023
Q4 		$4.13M Sell
410,057
-221,712
-35% -$2.03M ﹤0.01% 2948
2023
Q3 		$5.92M Buy
+631,769
New +$9.01M ﹤0.01% 2543
2023
Q2 		– Sell
-57,451
Closed -$1.34M – 6729
2023
Q1 		$1.34M Buy
57,451
+11,760
+26% +$301K ﹤0.01% 3819
2022
Q4 		$1.16M Sell
45,691
-243,479
-84% -$5.97M ﹤0.01% 4022
2022
Q3 		$5.58M Sell
289,170
-398,029
-58% -$10.1M ﹤0.01% 2792
2022
Q2 		$17.5M Sell
687,199
-4,060,995
-86% -$94.8M 0.01% 1441
2022
Q1 		$122M Buy
4,748,194
+3,780,369
+391% +$112M 0.06% 267
2021
Q4 		$40.5M Buy
967,825
+802,652
+486% +$31.4M 0.02% 865
2021
Q3 		$7.19M Sell
165,173
-151,977
-48% -$6.58M ﹤0.01% 2451
2021
Q2 		$15M Buy
317,150
+276,771
+685% +$12.6M 0.01% 1474
2021
Q1 		$2.07M Sell
40,379
-65,300
-62% -$3.52M ﹤0.01% 3501
2020
Q4 		$2.83M Buy
+105,679
New +$3.43M ﹤0.01% 2945
2020
Q3 		– Sell
-11,222
Closed -$460K – 4850
2020
Q2 		$460K Buy
+11,222
New +$377K ﹤0.01% 3451

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Israel Englander's VIR Position: Q2 2026 in Review

Israel Englander reduced its Vir Biotechnology (VIR) stake by 90% in Q2 2026, selling an estimated $4.2M and leaving 47,993 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #4784.

Israel Englander first reported a position in VIR in Q2 2020 and has held it in 23 quarters since. The position peaked at $122M in Q1 2022. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Israel Englander held 47,993 shares of Vir Biotechnology worth $489K as of Q2 2026.
  • Israel Englander sold 441,367 Vir Biotechnology shares in Q2 2026, an estimated $4.2M.
  • Vir Biotechnology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4784 holding.
  • Israel Englander first reported a position in Vir Biotechnology in Q2 2020 and has held it in 23 quarters since.
  • Israel Englander's Vir Biotechnology position peaked at $122M in Q1 2022.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.